SCHEMBL4454315

SCHEMBL4454315

CCCCC(C(=O)O)c1cc(-c2ccc(C(F)(F)F)cc2)cc(C2CCCN(S(=O)(=O)c3cccc4cnccc34)C2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 11/20 0.44
ROCK1 Q13464 10/20 0.44
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
NFKB1 P19838 1/20 0.40
PRKD3 O94806 1/20 0.40
PRKCG P05129 1/20 0.40
PRKCB P05771 1/20 0.40
PRKCA P17252 1/20 0.40
PRKCH P24723 1/20 0.40
PRKCI P41743 1/20 0.40
PRKCE Q02156 1/20 0.40
PRKCQ Q04759 1/20 0.40
PRKCZ Q05513 1/20 0.40
PRKCD Q05655 1/20 0.40
PRKD1 Q15139 1/20 0.40
BCL9 O00512 3/20 0.39
CTNNB1 P35222 3/20 0.39
CHRM1 P11229 3/20 0.39
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL478291 0.92 PSEN1 (0.46) ROCK2ROCK1CYP3A4CYP2D6NFKB1
SCHEMBL12012784 0.88 BCL9 (0.42) ROCK2ROCK1CYP3A4CYP2D6NFKB1
SCHEMBL478119 0.87 BCL9 (0.42) ROCK2ROCK1CYP3A4CYP2D6NFKB1
SCHEMBL4454311 0.86 ROCK2 (0.45) ROCK2ROCK1CYP3A4CYP2D6NFKB1
SCHEMBL4454318 0.85 ROCK2 (0.45) ROCK2ROCK1CYP3A4CYP2D6NFKB1
SCHEMBL12013100 0.79 ROCK2 (0.42) ROCK2ROCK1CYP3A4CYP2D6NFKB1
SCHEMBL478086 0.77 PSEN1 (0.52) BCL9CTNNB1SMN1; SMN2
SCHEMBL2913923 0.76 ROCK2 (0.42) ROCK2ROCK1CYP3A4CYP2D6NFKB1
SCHEMBL478039 0.74 PSEN1 (0.56) BCL9CTNNB1
SCHEMBL478136 0.74 BCL9 (0.53) BCL9CTNNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090105275-A1 PIPERIDINYL AND PIPERAZINYL MODULATORS OF y-SECRETASE JANSSEN PHARMACEUTICA N.V. (BE) 2009-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105275-A1 PIPERIDINYL AND PIPERAZINYL MODULATORS OF y-SECRETASE BACE1, BACE2, PSEN1 ROCK2 1145/4885ROCK1 668/4885CYP3A4 1969/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.